Improved IRS: evaluating the neonicotinoid, clothianidin...

In the News

This content is password protected. To view it please enter your password below:

Announcement: Provision of goods and services to IHI in 2019/20

(Dar es Salaam) IHI invites applications from eligible, competent and qualified companies for the prequalification to provide goods and services for the 2019/2020 financial year. Learn more about this here: …

Recent Projects

Calcium supplementation on pregnant women

Project summary This is a trial-based study funded by the Bill and Melinda Gates Foundation. It intends to generate evidence for decision-making on the potential non-inferiority of a lower dose …

Sustainable, Healthy, Learning Cities and Neighbourhoods

The Sustainable, Healthy, Learning Cities and Neighbourhoods is an exciting project in which IHI works with a consortium of partners from Asia and Africa to 1) develop capacity for improved …

Phase II Experimental hut and Phase III community study for Evaluation of SumiShield 50WG for Indoor Residual Spraying (IRS) in Tanzania

There is a long history of using indoor residual spraying (IRS) for malaria control and it has proved very effective in Tanzania and other countries. However, the usefulness of IRS is under threat due to increasing mosquito resistance to all 4 classes of insecticides. We are evaluating the neonicotinoid clothianidin as an insecticide for IRS in Tanzania.

irs-pic-2This insecticide has good potential for use in IRS against malaria vectors. Laboratory and field trials have shown great promise resulting in the new product being submitted to the WHO Pesticide Evaluation Scheme (WHOPES) for evaluation and recommendation.

By conducting the study in Tanzania we will obtain evidence needed by National Malaria Control Program (NMCP) for their objective to improve Integrated Vector Management to consider new innovations especially those that address the emerging threat of insecticide resistance and preserving the effectiveness of modern malaria vector control.

 

 

Lead Scientists:

Sarah Moore

Adam Saddler

Partners

National Institute of Medical Research

Funders

World Health Organization

Projects Location

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016